Skip to main content
Premium Trial:

Request an Annual Quote

Ibis Biosciences Wins $1.2M NIH Subcontract for Flu Detection Assays

NEW YORK (GenomeWeb News) - Ibis Biosciences, a subsidiary of Isis Pharmaceuticals, said yesterday that has been awarded a $1.2 million subcontract from the National Institutes of Health to study how influenza viruses are transmitted.
Ibis is conducting the research through a subcontract with its partner the Lovelace Respiratory Research Institute. The grant will sponsor assay development and sample characterization for viruses including the H5N1 strain, which causes avian flu.
Ibis will use its T5000 Biosensor System and a methodology called Triangulation Identification for the Genetic Evaluation of Risks, which it said is “a combination of genomics, mathematical modeling, mass spectrometry and molecular amplification.”
The expanded influenza detection assays Ibis and LRRI plan to develop will “uniquely identify and characterize influenza strains and aid in the tracking of influenza transmissions,” the company said.  

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.